REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/03/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ST13
US500000079291398Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the blue wording "ZIONEXA". The middle horizontal line of "E" is red. A red arrow appears on the left side of the "X". The white background is not a feature of the mark.
Titulares
Representantes
Marina Dostal GE Precision Healthcare LLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Radiopharmaceuticals for treating oncological diseases; in-vivo diagnostic markers used for detection and monitoring of oncological therapy; pharmaceutical preparations for human and veterinary use for treating oncological diseases; biological preparations for medical use for treating cancer; chemical preparations for medical use for treating cancer; food supplements and nutritional supplements for medical use; dietetic food and beverages for medical and pharmaceutical use; homeopathic supplements; plant therapy compositions, namely, medicinal teas; sanitary tampons for medical purposes; medicated bath preparations; dietetic beverages for medical use; chemical diagnostic reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medicated douching preparations; medical plasters; medical dressings; surgical and medical dressings
Classe 10
Medical devices for diagnostic use for administering contrast media; medical diagnostic instruments for detecting cancer; surgical apparatus and instruments; medical instruments for collection of human body fluids; kits primarily comprised of surgical instruments; containers for medical cancer samples; medicine administering tubes for surgical applications; container holders specifically adapted for holding medical samples; medicine administering tubes for medical applications; syringes for medical use; syringe needles for medical use; containers especially adapted for depositing medical syringes
Classe 41
Training services in the fields of healthcare, pharmaceuticals, medical research, pharmaceutical, and medicine development; publication of books and texts other than advertising texts in the pharmaceutical, medical and health fields; arranging and conducting of colloquiums, conferences, congresses, seminars in the pharmaceutical, medical and health fields
Classe 42
Development of pharmaceutical products; pharmaceutical research and development; testing in the form of quality control for others of pharmaceutical products; carrying out clinical trials for pharmaceutical products for others; scientific research regarding medicine; computer bio-informatic system, chemical and biological analysis; research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological and bio-informatic research services in the field of chemical, biological and pharmaceutical products; software design and development in the field of pharmaceutical, health and medical research; Providing medical and scientific research information in the field of pharmaceutical products and clinical trials; research on chemical reagents for medical use, namely, biomarkers; design of databases in the field of pharmaceutical research and development, medicine, genetics and clinical trials
Classe 44
Dispensing of pharmaceuticals services; pharmaceutical advice; medical services; medical information services; providing medical information; information services on the treatment of diseases via an awareness program; providing information with respect to pharmaceuticals
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/03/2026
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/08/2024
NEW REPRESENTATIVE AT IB RECEIVED
31/05/2024
NEW REPRESENTATIVE AT IB RECEIVED
24/11/2023
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2023
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2023
NEW REPRESENTATIVE AT IB RECEIVED
19/02/2023
NEW REPRESENTATIVE AT IB RECEIVED
11/12/2021
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/08/2021
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/08/2021
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/08/2021
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/08/2021
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/08/2021
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/08/2021
FINAL DECISION TRANSACTION PROCESSED BY IB
28/06/2021
FINAL DISPOSITION NOTICE SENT TO IB
03/06/2021
FINAL DISPOSITION PROCESSED
03/06/2021
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/06/2021
REGISTERED-PRINCIPAL REGISTER
02/03/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/12/2020
PUBLISHED FOR OPPOSITION
15/12/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/11/2020
REFUSAL PROCESSED BY IB
14/11/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2020
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2020
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2020
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/10/2020
REFUSAL PROCESSED BY MPU
24/10/2020
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/10/2020
NON-FINAL ACTION WRITTEN
02/10/2020
ASSIGNED TO EXAMINER
01/10/2020
APPLICATION FILING RECEIPT MAILED
18/08/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/08/2020
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/08/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.